MLchartDataset catalogue

sofosbuvir

Term · Oncology and biomedicine · MLC-T-ONC-016815

An orally available nucleotide prodrug and a hepatitis C virus (HCV) NS5B polymerase inhibitor with potential HCV inhibiting activity. Upon oral administration, sofosbuvir is metabolized to 2'-deoxy-2'-alpha-fluoro-beta-C-methyluridine-5'-monophosphate, which is then converted into the active triphosphate nucleotide that inhibits the NS5B polymerase, thereby preventing viral replication. The HCV NS5B protein, an RNA-dependent RNA polymerase, is essential for the replication of the viral HCV RNA genome.

Table 1. Record
IdentifierMLC-T-ONC-016815
FieldOncology and biomedicine
Synonymsnucleotide NS5B inhibitor GS-7977
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016815",
  "term": "sofosbuvir",
  "field": "Oncology and biomedicine",
  "definition": "An orally available nucleotide prodrug and a hepatitis C virus (HCV) NS5B polymerase inhibitor with potential HCV inhibiting activity. Upon oral administration, sofosbuvir is metabolized to 2'-deoxy-2'-alpha-fluoro-beta-C-methyluridine-5'-monophosphate, which is then converted into the active triphosphate nucleotide that inhibits the NS5B polymerase, thereby preventing viral replication. The HCV NS5B protein, an RNA-dependent RNA polymerase, is essential for the replication of the viral HCV RNA genome.",
  "synonyms": [
    "nucleotide NS5B inhibitor GS-7977"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/sofosbuvir/"
}

Record 15,160 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.